Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sagimet Biosciences Inc.

3.74
+0.23006.55%
Post-market: 3.780.0400+1.07%18:53 EDT
Volume:281.00K
Turnover:1.04M
Market Cap:120.41M
PE:-2.90
High:3.80
Open:3.55
Low:3.50
Close:3.51
Loading ...

Sagimet Biosciences initiated with a Buy at JonesResearch

TIPRANKS
·
27 Jan

With 43% stake, Sagimet Biosciences Inc. (NASDAQ:SGMT) seems to have captured institutional investors' interest

Simply Wall St.
·
20 Jan

Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Sagimet Biosciences, Inc. Class A (SGMT)

TIPRANKS
·
13 Jan

Promising Potential of Denifanstat Drives Buy Rating for Sagimet Biosciences

TIPRANKS
·
13 Jan

BRIEF-Sagimet Biosciences Announces Oral Presentation At The 9th Annual MASH-TAG 2025 Conference

Reuters
·
06 Jan

Sagimet Biosciences Announces Oral Presentation at the 9TH Annual Mash-Tag 2025 Conference

THOMSON REUTERS
·
06 Jan

Sagimet Biosciences Announces Oral Presentation at the 9th Annual MASH-TAG 2025 Conference

GlobeNewswire
·
06 Jan

Sagimet Biosciences (NASDAQ:SGMT) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.
·
15 Dec 2024

Analysts Offer Insights on Healthcare Companies: Chromadex (CDXC) and Sagimet Biosciences, Inc. Class A (SGMT)

TIPRANKS
·
08 Dec 2024

BUZZ-Sagimet rises as Oppenheimer initiates coverage with 'outperform'

Reuters
·
07 Dec 2024

Oppenheimer Initiates Sagimet Biosciences at Outperform With $30 Price Target

MT Newswires Live
·
06 Dec 2024

Sagimet Biosciences Initiated at Outperform by Oppenheimer

Dow Jones
·
06 Dec 2024

Sagimet Biosciences Inc : Oppenheimer Initiates Coverage With Outperform Rating; Price Target $30

THOMSON REUTERS
·
06 Dec 2024

Sagimet Biosciences initiated with an Outperform at Oppenheimer

TIPRANKS
·
06 Dec 2024

Sagimet Biosciences to Participate in the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire
·
26 Nov 2024

Sagimet Biosciences participates ik,on No

TIPRANKS
·
20 Nov 2024